Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Voluven® for the Prevention of Hypotension During Spinal Anesthesia for Cesarean Section

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* elective cesarean section applying spinal anesthesia~* ≥ week 37 of gestation~* Singleton pregnancy~Exclusion Criteria:~* Suspicion of any hypertensive disease~* Parturient in labor

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group A (Type: EXPERIMENTAL): 500 mL of HES 130/0.4 (6%) and 500 mL Ringer's Lactate Solution
- Group B (Type: ACTIVE_COMPARATOR): 1000 mL Ringer's Lactate solution

Based on this trial design, predict the completion outcome and termination type (if applicable).